← All organizations
Government of Japan
GovernmentWebsite ↗
Also known as: CellBank of Japan | Cooperative Study Group A for Hematology | Japan Science and Technology Agency | Ministry of Health, Labour and Welfare, Japan | National Institute of Infectious Diseases, Tokyo, Japan | Tokyo Shinagawa Hospital | Tokyo Shinagawa Hospital Medical Corporation Association, Japan
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1993Last known activity
Dec 16, 2023
Timeline
1880s
- Jan 1, 1889
Government of Japan— Founded
Drugs by trial phase (69 distinct, 55 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (40 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Anemia, Aplastic
- Asthma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Colorectal Neoplasms
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Fallopian Tube Neoplasms
- Heart Failure
- Hemoglobinuria, Paroxysmal
- HIV Infections
- Hypercholesterolemia
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypertension
- Infarction
- Infections
- Intermittent Claudication
- Kidney Diseases
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia-Lymphoma, Adult T-Cell
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Leukemia, T-Cell
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
- Muscle Spasticity
- Myelodysplastic Syndromes
- Myocardial Infarction
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Neoplasms, Second Primary
- Ovarian Neoplasms
- Pancoast Syndrome
- Pancytopenia
- Pericardial Effusion
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Peritoneal Neoplasms
- Polycystic Kidney, Autosomal Dominant
- Polycystic Kidney Diseases
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Small Cell Lung Carcinoma
- Stomach Neoplasms
- Stress Disorders, Post-Traumatic
- Stress Disorders, Traumatic
- Stroke
- Syndrome
- Thrombocytopenia
- Uterine Cervical Neoplasms
Recent trials (50)
- NCT06223919CollaboratorPhase 3Dec 16, 2023
- NCT05172037CollaboratorPhase 3Oct 28, 2021
- NCT04847661CollaboratorPhase 2/Phase 3Mar 28, 2021
- NCT04048343Overall official - principal investigatorPhase 3Jun 10, 2019
- NCT03351400CollaboratorPhase 1Nov 15, 2017
- NCT02276937CollaboratorPhase 2Oct 1, 2014
- NCT01910363CollaboratorPhase 2/Phase 3Jul 1, 2013
- NCT01673308CollaboratorPhase 2Aug 1, 2012
- NCT01294761CollaboratorN/AFeb 1, 2011
- NCT01214343Lead sponsorPhase 3Oct 1, 2010
- NCT01145846Lead sponsorPhase 3May 1, 2010
- NCT01145976Lead sponsorPhase 3Mar 1, 2010
- NCT01145976Reponsible party - principal investigatorPhase 3Mar 1, 2010
- NCT01146977Lead sponsorPhase 2Jan 31, 2010
- NCT01146977Sponsor investigatorPhase 2Jan 31, 2010
Details
- Founded
- Tokyo, JP Jan 1, 1889
- Last known activity
- Dec 16, 2023